Cancer Genetics Inc (NASDAQ:CGIX)

8.51
Delayed Data
As of 3:59pm ET
 -0.04 / -0.47%
Today’s Change
4.83
Today|||52-Week Range
19.99
+27.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues1.9M1.4M1.5M3.2M
 
 
 
 
 
Cost of Goods Sold1.3M1.2M1.4M2.3M
 
 
 
 
 
Depreciation And Amortization87.7K103.5K124.4K279.9K
 
 
 
 
 
 
Operating ExpensesGross Income490.5K140.3K8.6K656.1K
 
 
 
 
 
General Expenses3.2M4.1M4.1M5.2M
 
 
 
 
 
Research And Development806.1K596.8K807.8K1.0M
 
 
 
 
 
Total Operating Expenses4.6M5.4M5.6M7.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-3.9M-4.1M-4.6M
 
 
 
 
 
Extraordinary Credit537.0K0.00239.0K129.0K
 
 
 
 
Extraordinary Charge0.00-44.0K0.000.00
 
 
Pre-Tax Equity Earnings-----298.0K-349.2K
 
 
 
Interest Expense On Debt348.0K341.2K30.7K36.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.5M-4.3M-4.2M-4.8M
 
 
 
 
 
Income Taxes0.00-1.8M0.000.00
 
 
Net Income-2.5M-2.5M-4.2M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.3M9.3M9.3M9.6M
 
 
 
 
 
Shares To Calculate EPS Diluted9.3M9.3M9.3M9.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.27-$0.47-$0.51
 
 
 
 
 
EPS Diluted-$0.33-$0.27-$0.47-$0.51
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account